Prime Pac PRRS RR (Canada)
This treatment applies to the following species:PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME VACCINE, Reproductive and Respiratory Form, Modified Live Virus
This product has been shown to be effective for the vaccination of healthy swine 3 weeks of age or older against respiratory disease caused by Porcine Reproductive and Respiratory Syndrome (PRRS) virus and for the vaccination of breeding age female against reproductive disease caused by PRRS virus. Duration of Immunity against reproductive disease is at least 20 weeks; duration of immunity against respiratory disease has not been established.
To review efficacy and safety data, go to productdata.aphis.usda.gov.
ADMINISTRATION/DOSAGE: Sows and gilts: Inject a single 1 mL dose intramuscularly (IM) 8 weeks prior to breeding. Piglets: Inject a single 1 mL dose IM at 3 weeks of age or older. For advice on re-vaccination frequency, contact your veterinarian.
PREPARATION OF THE VACCINE:
1. Do not rehydrate the vaccine until ready for use.
2. Mix only one set of vials at a time and use entire contents promptly after rehydration.
3. Using a sterile transfer needle, transfer the entire contents of sterile diluent into the bottle of freeze dried vaccine and shake the combined vaccine and diluent to suspend evenly. The vaccine is now ready for use.
Prime Pac PRRS RR Caution
Vaccine virus can shed and be transmitted to other populations of swine in direct or indirect contact with vaccinated swine. The duration of potential vaccine virus transmission may vary. Non-vaccinated pigs in contact with modified live PRRS-vaccinated pigs may seroconvert to vaccine virus. Use of the vaccine in herds intended to remain PRRS virus seronegative is contraindicated.
Introduction of vaccinated pigs into herds intended to remain PRRS virus seronegative is contraindicated.
Store at 2° to 8°C (35° to 46°F). Use aseptic technique and only sterile needles and syringes to inject the vaccine. Use entire contents when first opened. Do not mix with other products. Dispose of containers and all unused vaccine according to local biohazardous waste disposal regulations. Do not vaccinate within 21 days before slaughter. Not for use in pregnant sows or boars. If allergic response occurs, administer epinephrine. In case of human exposure, contact a physician.
PRESERVATIVE: Gentamicin
FOR ANIMAL USE ONLY
Intervet Inc. d/b/a Merck Animal Health, Omaha, Nebraska 68103 USA
VLN 165A/PCN 19T1.21
1 866 683-7838 (Canada)
|
Code |
|
100 Doses Rehydrate to 100 mL |
173994 |
195811-01 |
CPN: 1208314.1
Intervet Canada Corp.
16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk: | 514-428-7013 | |
Toll-Free: | 866-683-7838 | |
Fax: | Toll-free 888-498-4444; local 514-428-7014 | |
Website: | www.merck-animal-health.ca |
![]() |
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details. |
Copyright © 2025 Animalytix LLC. Updated: 2025-05-29
Elsewhere on our site...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Phentermine
Phentermine is an appetite suppressant used together with diet and exercise to treat obesity. Learn ...
Semaglutide
Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular ...